How to Read a Peptide COA: 12 Checks Before You Trust the Document

Short answer: Start by matching the certificate of analysis to the exact product and lot. Then verify who performed the work, when it was performed, which methods were used, what each result actually measures, and whether the supporting data and report can be authenticated. A COA is evidence about a tested sample. It is not proof of safety, effectiveness, regulatory approval, or every vial in circulation.

This guide is for evaluating public evidence. It is not medical advice and does not recommend purchasing, possessing, or using any peptide.

What a peptide COA is

A certificate of analysis, or COA, is a document reporting test results for an identified material or sample. The title alone does not tell you how the sample was obtained, whether the methods were suitable, whether the file is authentic, or whether the report applies to the lot being offered today.

A strong COA makes its claims auditable. A weak one may contain a purity percentage and a logo but omit the details needed to connect the result to a sample or interpret what was measured.

The central rule is simple: read each result as an answer to one defined analytical question. Identity, chromatographic purity, peptide quantity, sterility, and bacterial endotoxin are not interchangeable.

The 12-check peptide COA review

1. Identify the laboratory

Look for the laboratory’s legal name, address, contact information, and report issuer. Search the laboratory’s own website for a matching verification system or contact channel rather than relying only on links supplied by the vendor.

If the report mentions accreditation, verify the accreditation body, certificate status, and scope. ISO/IEC 17025 addresses laboratory competence, but an accreditation claim does not mean every possible test is within the laboratory’s accredited scope. It also does not prove the submitted sample was independently selected.

Record the result as verified, partially verified, or not verified. Do not turn an unverifiable public claim into an accusation; state the evidence gap.

2. Confirm the report is final

Check for a final-report designation, authorized signature or approval, report identifier, page numbers, and revision history. Draft, preliminary, or cropped documents may omit qualifications or later corrections.

If pages are numbered “1 of 3,” all three should be present. If a report was amended, the current version and reason for revision matter.

3. Match the product and analyte

The COA should name the material tested. Compare spelling, salt form, modification, and sequence-related description with the product claim. A report for one chemical form should not be assumed to cover another.

Ambiguous labels such as “sample A” can still be useful if another traceable record connects that identifier to the product. Without that bridge, the public document cannot independently establish the match.

4. Match the lot or batch

Find the vendor lot or batch number on both the report and the offered product. A report with no lot identifier may show that a similar item was tested at some point, but it is weaker evidence for current inventory.

Watch for recycled reports: an old report date, a current product page, and no disclosed lot relationship. PeptidesReview.org will describe these as historical, current-lot matched, or lot match not established.

5. Trace the sample and submitter

Ask who selected, purchased, handled, and submitted the sample. Common provenance categories are:

• Vendor-submitted sample.
• Retail-purchased sample with a documented purchaser.
• Independently commissioned sample with controlled submission.
• Chain of custody not publicly reported.

“Third-party tested” usually describes who ran the analysis, not who controlled sampling. A vendor-submitted result may still be genuine laboratory evidence, but it does not eliminate selection bias or establish that the sample represents all retail units.

6. Check the dates

Record the sample receipt date, analysis date, report date, and any retest or expiration date. These dates answer different questions.

A recent upload is not necessarily a recent test. A result can remain relevant as historical evidence, but the age and lot relationship should be visible to the reader.

7. Separate identity from purity

An identity result asks whether evidence is consistent with the expected analyte. A chromatographic-purity result asks how the detected material separated under a stated method.

Mass spectrometry can provide molecular-mass evidence, and MS/MS can add sequence-related information. HPLC can show a main peak and detectable related peaks under the method. Neither label should be treated as a universal conclusion without the result, conditions, and supporting output.

The peer-reviewed paper Reference Standards to Support Quality of Synthetic Peptide Therapeutics describes using multiple orthogonal techniques because closely related structures, isomers, counterions, residual moisture, and other attributes are not all resolved by one measurement.

8. Read the purity basis

If the report says “99% purity,” determine what the percentage means. Common possibilities include chromatographic main-peak area, purity on a dry-weight basis, or a mass-balance result. They are not equivalent.

For HPLC area percent, look for the detector, wavelength, integration approach, column, mobile phases, gradient, sample concentration, and whether all relevant peaks were included. Co-elution or unequal detector response can limit a simple area-normalization interpretation.

The synthetic-glucagon mass-balance study measured water, counterion-related material, inorganic ions, and peptide impurities separately. That illustrates why a high chromatographic area percentage should not automatically be read as the fraction of total vial mass that is peptide.

9. Check whether quantity was tested

If the product claims an amount per vial, look for an actual quantitative assay. The report should state the amount, units, calculation basis, reference standard, and method.

Identity plus HPLC area percent does not necessarily verify net peptide content. Recommendations for peptide reference materials specifically distinguish peptide content from peptide purity; see Recommendations and Best Practices for Reference Standards and Reagents Used in Bioanalytical Method Validation.

Mark the amount claim as verified by a stated assay, partially supported, or not tested on the public report.

10. Treat sterility and endotoxin as separate results

Sterility testing addresses detection of viable microorganisms in tested units under stated conditions. A bacterial endotoxins test addresses endotoxin, typically with a defined unit and limit. One does not substitute for the other.

For sterility, note the method, sample units, result, and dates. For endotoxin, note the method, units, limit, dilution, and controls. FDA’s Pyrogen and Endotoxins Testing Q&A explains that test-article properties can interfere with endotoxin assays, which is why a bare “pass” is less informative than a result with method context.

Do not infer either attribute from HPLC or mass spectrometry.

11. Inspect the supporting output

Where available, review chromatograms, spectra, peak tables, calculations, and acceptance criteria. Supporting output makes the conclusion more interpretable, but screenshots alone are not automatically conclusive.

Ask:

• Does the sample ID match across every page?
• Are axes, peaks, and units labeled?
• Is the reported result traceable to the displayed calculation?
• Are excluded peaks or integration choices explained?
• Is there a system-suitability or quality-control result?

The ICH Q2(R2) guideline emphasizes accuracy, precision, specificity/selectivity, and the reportable range according to the intended use. A COA need not reproduce a full validation package, but the public result should not imply more certainty than its method context supports.

12. Verify the document independently

Prefer a laboratory-hosted verification page, report code, QR destination on the laboratory’s domain, digital signature, or direct confirmation from a laboratory contact obtained independently.

Check the destination before trusting a QR code. A vendor-hosted PDF can reproduce a real report, but laboratory-side verification provides a stronger authenticity path. Record the date you verified it because URLs, certificates, and report statuses can change.

Original analysis: a four-part COA evidence record

PeptidesReview.org will not collapse a COA into one opaque “quality score.” We will record four evidence dimensions separately.

Dimension | Verified | Partially verified | Not reported or not verified

Document integrity | Final report and authenticity path confirmed | Report appears complete but independent verification is unavailable | Draft, incomplete, conflicting, or source unknown

Sample traceability | Product, lot, sample ID, dates, and provenance align | Some identifiers align but a link is missing | Current-lot relationship cannot be established

Analytical completeness | The tests match the public claims and state their result basis | Some claims are tested; others are omitted or ambiguous | Method or result does not answer the claim

Interpretability | Methods, units, criteria, and supporting output are sufficient to understand the result | A conclusion is reported with limited supporting detail | Result basis cannot be determined

This structure lets readers see why a document is strong or limited. It avoids pretending that a mathematically precise score can convert incomplete public evidence into a safety conclusion.

COA warning signs that require follow-up

These are verification gaps, not automatic proof of misconduct:

• No laboratory name or a laboratory identity that cannot be independently located.
• No report ID, no final status, or missing pages.
• No lot or batch number connecting the report to inventory.
• A purity percentage with no stated method or calculation basis.
• HPLC purity presented as if it were amount per vial.
• “Mass spec passed” without expected and observed results.
• “Sterile” inferred from chemical tests.
• “Endotoxin free” without method, units, limit, and result.
• Dates or sample identifiers that conflict across pages.
• A QR code that resolves only to a vendor-controlled page when laboratory verification is claimed.
• Accreditation language without an identifiable certificate, body, or relevant scope.
• A cropped image that removes signatures, qualifications, footnotes, or revision information.

The appropriate response is to request the complete final report and document what remains unknown.

A reusable COA review worksheet

For each public report, capture:

1. Report URL and archived copy, where lawful and appropriate.
2. Laboratory name and verification URL.
3. Report ID and revision.
4. Vendor or submitting party.
5. Product/analyte and form.
6. Vendor lot/batch and laboratory sample ID.
7. Receipt, analysis, and report dates.
8. Sampling and chain-of-custody classification.
9. Identity method and result.
10. Purity method, result, and calculation basis.
11. Quantity method and result, if claimed.
12. Sterility and endotoxin methods and results, if claimed.
13. Supporting output present or absent.
14. Method limitations and report qualifications.
15. Last verification date and correction history.

That record can be updated when a vendor posts a new lot, a laboratory confirms authenticity, or a report is corrected.

Limitations

• COA formats vary, and not every legitimate laboratory report contains the same fields.
• Public documents may omit validation, uncertainty, raw data, or chain-of-custody information retained elsewhere.
• ISO/IEC 17025 accreditation is scope-specific and should be verified with the applicable accreditation body.
• Pharmaceutical analytical guidance is used here as an evidence-quality benchmark; it may not be a legal requirement for every research product.
• A technically credible result still applies only to the tested sample and conditions.

What this does not prove

Completing these 12 checks does not prove that a peptide is safe, effective, approved, legally marketed, made under suitable manufacturing controls, or appropriate for human use. It does not prove that every vial in a lot is identical or that an independently generated result will match the vendor-submitted sample.

The correct conclusion is limited: the document provides stronger or weaker support for specific analytical claims. Anything beyond that requires additional evidence.